Table 2 Clinical characteristics associated with visual acuity at month 3.
Univariate analysis | Multiple regression analysis | |||
|---|---|---|---|---|
r | P | β | P | |
Age, years | 0.48 | 0.025* | ||
Sex | -0.18 | 0.42 | ||
Oral anticoagulants | 0.43 | 0.048* | ||
Duration, days | 0.54 | 0.012* | ||
BCVA at baseline | 0.22 | 0.32 | ||
Maximum diameter of the SMH lesion, DD | 0.079 | 0.73 | ||
Foveal height of the SMH lesion, µm | -0.20 | 0.36 | ||
Inner retinal hemorrhage | 0.34 | 0.13 | ||
Greatest linear diameter of RPE tear ≧ 1DD | -0.57 | 0.011* | -0.43 | 0.016* |
RPE tear that extended into 1 DD of the foveal center | -0.45 | 0.040* | ||
Blood displacement | 0.16 | 0.16 | ||
SMH recurrence within 3 months | -0.62 | 0.0023* | -0.32 | 0.085 |
Anti-VEGF within 3 months after surgery | -0.42 | 0.053 | ||
Treatment naive | 0.53 | 0.012* | 0.38 | 0.042* |
